LONDON UROLOGY LIMITED
💤Zombieactive
06300338 · ltd · incorporated 2007-07-03
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Jul 2025
Net worth
£1.21M
book net assets
Opportunity
80/100
Exceptional
What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
PursueAsset-holding vehicle with a 77-year-old founder — textbook succession opportunity.
Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (83/100, director aged 77). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
4 officers (2 active, 4 linked, 1 with DOB)
75
Ownership & PSC
1 active PSC(s) of 2 total, 2 with control declared
90
Director network
8 connected companies via shared directors
69
Filing history
54 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
80/100Exceptional
PassWatchWorth a lookStrongExceptional
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Business quality
70
Active, clean filings, stable charge profile.
Acquirability
80
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredPositive net assets
Net assets £1,209,421
Cash YoY
-4%
Year on year
Key financials
2 years extracted from filed iXBRL accountsCash
£1.1m
↓ 4.3% YoY
Net Worth
£1.2m
↑ 1.4% YoY
Current Assets
£1.3m
↑ 2.8% YoY
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-07-31 | 2024-07-31 |
|---|---|---|
| Total assets | £1.21M | £1.20M |
| Current assets | £1.27M | £1.24M |
| Cash | £1.07M | £1.12M |
| Debtors | £197.3k | £114.1k |
| Net assets | £1.21M | £1.19M |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
0
filings
Last 90 days
2
filings
- • 1 accounts
- • 1 confirmation-statement
Last 180 days
2
filings
- • 1 accounts
- • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (21 events)Click to expand
- 2026-04-14📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-03-05📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-02-01📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-01-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-03-30📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2022-03-30📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2022-01-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-12-15📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2020-11-06📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-11-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-04-16📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-08-24📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2018-07-19📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-02-16📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2007-07-03🏢Company incorporatedAs LONDON UROLOGY LIMITED
- 2007-07-03➕BADENOCH, Michele Patricia appointedsecretary
- 2007-07-03➕BADENOCH, David Fraser appointeddirector
- 2007-07-03➕SAME-DAY COMPANY SERVICES LIMITED appointedcorporate-nominee-secretary
- 2007-07-03➖SAME-DAY COMPANY SERVICES LIMITED resignedcorporate-nominee-secretary
- 2007-07-03➕WILDMAN & BATTELL LIMITED appointedcorporate-nominee-director
- 2007-07-03➖WILDMAN & BATTELL LIMITED resignedcorporate-nominee-director
Owner dependency
100/100
Critical — business is the founderThe business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
FACTORS
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 19 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 77 — succession pressure is live.
Succession & seller-readiness
98/100
Likely off-market candidateStrong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
SIGNALS
- primaryFounder aged 70+: Senior director is approximately 77 years old. Natural succession window is now.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 19 years.
- secondaryStable-but-static management: Company is 19 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Michele Patricia Badenoch Individual · British · DOB 04/1958 · age 68 | 75–100% | 75–100% | 75-100% shares · 75-100% voting | 03/07/2018 |
1 historic (ceased) PSC
- Mr David Fraser Badenochceased 23/03/2022· 25-50% shares · 25-50% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
🔒Co-director network graph
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · WV postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 108 HEALTHCARE LIMITED→ 11369329 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| 3DS FUNHOUSE LIMITED→ 14080320 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| A.C.E-CARING LTD→ 15300347 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ACENDR LTD→ 15120238 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ACTIVE THERAPY LIMITED→ 08028459 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| ACTIVO CARE LIMITED→ 11625988 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ACTON BANKS HOME CARE LTD→ 13013886 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ADDCARE HEALTH UK LTD→ 13898153 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ADEY MEDICALS LTD→ 16245458 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ADJ HOLDINGS LIMITED→ 10425590 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AEE HEALTHCARE LTD→ 13356004 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AFC WOLVERHAMPTON CIC→ 15786870 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2007-07-03
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities
Registered office
Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB
England
Filing status
Accounts
Next due: 2027-04-30
Last made up to: 2025-07-31
Confirmation statement
Next due: 2027-04-06
Last: 2026-03-23
Officers (2 active · 2 resigned)
BADENOCH, Michele Patricia→
Activesecretary · appointed 2007-07-03
View their other companies + combined net worth →
BADENOCH, David Fraser→
Activedirector · ~77y · appointed 2007-07-03
View their other companies + combined net worth →
SAME-DAY COMPANY SERVICES LIMITED→
Resignedcorporate-nominee-secretary · appointed 2007-07-03 · resigned 2007-07-03
WILDMAN & BATTELL LIMITED→
Resignedcorporate-nominee-director · appointed 2007-07-03 · resigned 2007-07-03
Click a director name to see their full track record across all companies.
Recent filings (54 total)
accounts-with-accounts-type-total-exemption-full
accounts · AA
2026-04-14
confirmation-statement-with-updates
confirmation-statement · CS01
2026-04-07
confirmation-statement-with-updates
confirmation-statement · CS01
2025-04-02
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-03-05
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-04-12
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-02-01
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-04-26
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-01-24
confirmation-statement-with-updates
confirmation-statement · CS01
2022-03-30
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2022-03-30
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2022-03-30
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-01-19
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-12-09
confirmation-statement-with-updates
confirmation-statement · CS01
2020-12-15
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2020-12-15